Jl. Liesveld et al., PHENOTYPIC CHARACTERIZATION OF THE HUMAN FIBROUS HISTIOCYTOMA GIANT-CELL TUMOR (GCT) CELL-LINE AND ITS CYTOKINE REPERTOIRE, Experimental hematology, 21(10), 1993, pp. 1342-1352
The pleiotropic nature of malignant fibrous histiocytomas (MFH) is man
ifested as mixed cellular infiltrates consisting of myofibroblasts, hi
stiomonocytes, and neutrophils. We detail in this report the phenotypi
c characteristics of the human fibrous histiocytoma giant cell tumor (
GCT) cell line that establish its mesenchymal origin. The latter is un
derscored by the ability of GCT cells to express mRNA for transforming
growth factor P (TGF-beta) as well as both A and B chains of platelet
-derived growth factor (PDGF). GCT cells also support the binding of C
D34(+) cells, but less efficiently than do normal marrow stromal cells
. Since cytokines elaborated by MFH may mediate in part the recruitmen
t of monocytes and neutrophils into tumor-infiltrated tissues, we have
determined the cytokine repertoire of the GCT cell line, already know
n for its ability to elaborate colony-stimulating factors (CSFs) and i
nterleukin-1 (IL-1). GCT cells express IL-1 alpha, IL-1 beta, IL-6, ma
crophage colony-stimulating factor (M-CSF or CSF-1), granulocyte-macro
phage colony-stimulating factor (GM-CSF), granulocyte colony-stimulati
ng factor (G-CSF), and IL-8. No detectable mRNA for IL-3, IL-4, IL-7,
and tumor necrosis factor-alpha (TNF-alpha) was detected in GCT cells
by polymerase chain reaction (PCR). Expression of cytokine mRNAs was r
esponsive to agents such as dexamethasone (dex), 12-O-tetradecanoyl ph
orbol 13-acetate (phorbol diester or TPA), and TNF-alpha. Thus, this c
ell line provides a useful model for understanding the pathobiology of
MFH and hematopoietic progenitor interactions with mesenchymal/stroma
l cells.